Worldwide Emergence of Extensively Drug-resistant Tuberculosis

By N. Shah, A. Wright, G. Bai, L. Barrera, F. Boulahbal, N. Martín-Casabona, F. Drobniewski, C. Gilpin, M. Havelková, R. Lepe and 10 more. Emerging Infectious Diseases, 2007

605 citations recorded by the source corpus.

Mycobacterium tuberculosis strains are becoming resistant to not only the most powerful first-line drugs but also many second-line drugs.

Subfields: Epidemiology, Infectious Diseases, Surgery

View Paper: https://www.semanticscholar.org/paper/e3a4a4c391532d8155997b4384a3a9754c377e27

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Diacon
2. A. Pym
3. N. Lounis
4. M. Grobusch
5. K. Andries
6. R. Patientia
7. T. De Marez
8. J. Palomino

Citations in the corpus

• The diarylquinoline TMC207 for multidrug-resistant tuberculosis. (2009, background): “Chest pain 2 (9) 4 (17) Pharyngolaryngeal pain 1 (4) 2 ( 8 )”
• Antibiotic resistance: a rundown of a global crisis (2018, background): “both the developing and the developed world.(46,47) Other severe bacterial infections include Acinetobacter, Burkholderia, Campylobacter, Citrobacter, Clostridium, Enterobacter spp.”